They’re turning their backs on a technology thought to have saved millions of lives—with the potential to save many more.

HHS reinstates vaccine safety task force apparently in response to looming lawsuit deadline by group Secretary Kennedy ...

The Department of Health and Human Services’ mRNA pullback only applies to their use in upper respiratory disease, according ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

HHS' decision "could stagnate research that has the potential to save millions of lives," writes Simon Williams.

Messenger RNA vaccines have proven to be effective and are safer than standard vaccines, because they have fewer side effects ...

National Institutes of Health director Jay Bhattacharya believes mRNA vaccine technology is “promising” but has failed at ...

The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be ...

Director Jay Bhattacharya claims the federal government recently canceled millions of dollars’ worth of mRNA research contracts because the general public does not trust the technology. Bhattacharya ...

The NIH’s Jay Bhattacharya tried his best pitch to explain the Trump administration’s shift away from mRNA vaccine research.

RNA vaccines were a game-changer in the fight against COVID-19 — but now, their future could be shifting. The U.S. Department ...

This week, President Donald Trump called Operation Warp Speed, a public-private federal program that helped speed up the ...